« Previous
Next »
Titles
- Letter from Joshua Lederberg to Gordon Allen2
- Letter from Linus Pauling to Warren Weaver2
- Transformation of Pneumococcal Types2
- A risk-based approach to monitoring of clinical investigations questions and answers: guidance for industry1
- ACA state based marketplace public reporting: comparing open enrollment period 1 (OEP1) to open enrollment period 2 (OEP2)1
- Acceleration of Reactivation of Reduced Bovine Pancreatic Ribonuclease by a Microsomal System from Rat Liver1
- Acquisition of M Protein by Pneumococci through Transformation Reactions1
- Adaptive designs for clinical trials of drugs and biologics1
- Affinity Chromatography1
- Albert Szent-Gyorgyi discusses his approach to cancer research1
- Albert Szent-Gyorgyi discusses his approach to research1
- Allergic rhinitis: developing drug products for treatment1
- Anthrax: developing drugs for prophylaxis of inhalational anthrax1
- Assessing the usability of encounter data for enrollees in comprehensive managed care 2010-20111
- BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment1
- Bacterial vaginosis: developing drugs for treatment1
- Calculation of outcome rates that diagnose bedside performance: central-line-associated bloodstream infection1
- Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff1
- Considerations for building federal data capacity for patient-centered outcomes research related to intellectual and developmental disabilities1
- Considerations in demonstrating interchangeability with a reference product1